Beijing Beilu Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 680.84 million compared to CNY 623.55 million a year ago. Revenue was CNY 680.84 million compared to CNY 623.55 million a year ago. Net income was CNY 129.74 million compared to CNY 160.5 million a year ago. Basic earnings per share from continuing operations was CNY 0.2653 compared to CNY 0.3282 a year ago.